BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2011
View Archived Issues
Genosco and Oscotec disclose promising therapeutics for acute myeloid leukemia
Read More
New serine/threonine-protein kinase Chk1 inhibitor shows antitumor in vivo
Read More
Two new allosteric nicotinic acetylcholine alpha4beta2 receptor modulators described
Read More
Merz Pharmaceuticals NME shows antidyskinetic efficacy
Read More
XenoPort reports on combination therapies for Parkinson's disease
Read More
Phase III trial in autism meets endpoints
Read More
Novel histamine H3 receptor ligands patented by Sanofi
Read More
Janssen Biotech and Pharmacyclics enter agreement for anticancer drug
Read More
Amgen describes new ALK tyrosine kinase receptor inhibitors
Read More
Acacia Pharma discloses phase IIa data on APD-209
Read More
CeNeRx BioPharma to advance TriRima trial
Read More
Novel lysophospholipid S1P1 receptor modulators characterized at Allergan
Read More
NanoViricides requests pre-IND meeting with FDA for anti-influenza candidate
Read More
Merck & Co. discovers new PRCP inhibitors
Read More
Metabolex announces results from arhalofenate/febuxostat combination study
Read More
Boehringer Ingelheim provides update on BI-201335 program
Read More
Nissan Chemical presents novel adiponectin receptor protein 1 agonists
Read More
FDA approves new oxybutynin gel product
Read More
OZ-439 reduces parasitemia in proof-of-concept study
Read More
Unigene Laboratories regains worldwide rights to oral PTH program
Read More
Vertex and Alios BioPharma begin trials of hepatitis C drug candidates
Read More
New topline data released from elvitegravir trial
Read More
Neoprobe to change name
Read More
Gedeon Richter gains extended marketing rights for Esmya
Read More
Takeda Pharmaceutical to launch new global vaccine business
Read More
ENGAGE-501 study evaluates entinostat in Hodgkin's lymphoma
Read More
